Oral bioavailability, tissue distribution and depletion of flumequine in the food producing animal, chicken for fattening

Anadón, 1992, Pharmacokinetics of norfloxacin and its N-desethyl- and oxo-metabolites in broiler chickens, Am. J. Vet. Res., 53, 2084 Anadón, 1995, Pharmacokinetics and residues of enrofloxacin in chickens, Am. J. Vet. Res., 56, 501 Anadón, 2002, Pharmacokinetic characteristics and tissue residues for marbofloxacin and its metabolite N-desmethyl-marbofloxacin in broiler chickens, Am. J. Vet. Res., 63, 927, 10.2460/ajvr.2002.63.927 Atef, 1987, Some pharmacokinetics and microbiologic aspects of flumequine in chickens, Arch. Gefluegelk., 51, 88 Baggot, 1980, Distribution of antimicrobial agents in normal and diseased animals, J. Am. Vet. Med. Assoc., 176, 1085 Craig, 1993, Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens, Eur. J. Clin. Microbiol. Infect. Dis., S1, 6, 10.1007/BF02389870 Dalla Costa, 1996, AUIC – A general target for the optimisation of doping regimens of antibiotics?, Ann. Pharmacother., 30, 1024, 10.1177/106002809603000919 Delmas, 1997, Pharmacokinetics of flumequine in sheep after intravenous and intramuscular administration: bioavailability and tissue residue studies, J. Vet. Pharmacol. Ther., 20, 249, 10.1046/j.1365-2885.1997.00067.x Dorrestein, 1983, Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livia), J. Vet. Pharmacol. Ther., 6, 281, 10.1111/j.1365-2885.1983.tb00003.x Drusano, 1993, Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis, Antimicrob. Agents Chemother., 37, 483, 10.1128/AAC.37.3.483 EMEA (The European Agency for the Evaluation of Medicinal Products) 1995. Note for Guidance: Approach Towards Harmonisation of Withdrawal Periods. EMEA/CVMP/036/95, pp. 1–37. EMEA (The European Agency for the Evaluation of Medicinal Products) 1998. Guideline on Validation of Analytical Procedures: Methodology (VICH GL2). CVMP/VICH/591/98-FINAL, pp. 1–10. EMEA (The European Agency for the Evaluation of Medicinal Products) 2002. Committee for Veterinary Medicinal Products. Summary Report on Flumequine (Extension to all food producing species). EMEA/MRL/823/02-FINAL, pp. 1–2. EMEA (The European Agency for the Evaluation of Medicinal Products) 2002 Updated Application Software relating to Note for Guidance on Approach towards Harmonisation of Withdrawal Periods for Meat (see CVMP/036/95). EMEA/CVMP/563/02, p. 1. Forrest, 1993, Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients, Antimicrob. Agents Chemother., 37, 1073, 10.1128/AAC.37.5.1073 Gibaldi, 1982 Goren, 1982, Pharmacokinetical aspects of flumequine and therapeutic efficacy in Escherichia coli infection in poultry, Avian Pathol., 11, 463, 10.1080/03079458208436118 Greenwood, 1978, Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids, Antimicrob. Agents Chemother., 13, 479, 10.1128/AAC.13.3.479 Hansen, 1999, Single-dose pharmacokinetics of flumequine in halibut (Hippoglossus hippoglossus) and turbot (Scophthalamus maximus), J. Vet. Pharmacol. Ther., 22, 122, 10.1046/j.1365-2885.1999.00191.x Harrison, 1986, Disposition of radiolabeled flumequine in rat and dog, Drug Metab. Dispos., 14, 555 Madaras-Kelly, 1996, Twenty-four-hour area under the concentration–time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model, Antimicrob. Agents Chemother., 40, 627, 10.1128/AAC.40.3.627 Marchbanks, 1993, Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection, Antimicrob. Agents Chemother., 37, 1756, 10.1128/AAC.37.9.1756 Meijer, 1994, Bioavailability of flumequine after semisimultaneous administration to veal calves, Pharm. Res., 11, 117, 10.1023/A:1018962131274 Meinen, 1995, Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections, Am. J. Vet. Res., 56, 1219 Mevius, 1990, Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves, J. Vet. Pharmacol. Ther., 13, 159, 10.1111/j.1365-2885.1990.tb00764.x Mevius, 1990, In vitro activity of flumequine in comparison with several other antimicrobial agents against five pathogens isolated in calves in The Netherlands, Vet. Q., 12, 212, 10.1080/01652176.1990.9694268 Neuman, 1978, Flumequine, Drugs Today, 14, 365 Petersar, 1993, Quinolone resistance in clinical practice: occurrence and importance, 119 Pijpers, 1989, In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens, J. Vet. Pharmacol. Ther., 12, 267, 10.1111/j.1365-2885.1989.tb00670.x Raemdonck, 1992, In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials, Avian Dis., 36, 964, 10.2307/1591556 Riegelman, 1980, The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time, J. Pharmacokinet. Biopharm., 8, 509, 10.1007/BF01059549 Rogstad, 1993, Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater, Aquaculture, 110, 207, 10.1016/0044-8486(93)90369-A Ruiz-Garcia, 1999, Pharmacokinetics, bioavailability and absorption of flumequine in the rat, Eur. J. Pharm. Biopharm., 48, 253, 10.1016/S0939-6411(99)00057-0 Samaha, 1991, Pharmacokinetics and tissue residues of flumequine in chickens, Arch. Lebensmittelhyg., 42, 33 Samuelsen, 1997, Efficacy of bath-administered flumequine and oxolinic acid in the treatment of vibriosis in small Atlantic halibut, J. Aquat. Anim. Health, 9, 127, 10.1577/1548-8667(1997)009<0127:EOBAFA>2.3.CO;2 Schentag, 1991, Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationship between serum concentrations, MIC values, and bacterial eradication in patients with Gram-negative pneumonia, Scand J. Infect. Dis., S74, 218 Schentag, 1993, Pharmacodynamics of the fluoroquinolones, 259 Schentag, 2000, Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models, Clin. Infect. Dis., 31, 40, 10.1086/314059 Schuppan, 1985, Plasma and urine levels of flumequine and 7-hydroxyflumequine following single and multiple oral dosing, J. Antimicrob. Chemother., 15, 337, 10.1093/jac/15.3.337 Schwartz, 1978, Estimating the dimension of a model, Ann. Stat., 6, 461, 10.1214/aos/1176344136 Sheiner, 1981 Steer, 1981, Clinical and laboratory studies with R802, a new synthetic quinolone, in urinary tract infection, J. Antimicrob. Chemother., 7, 643, 10.1093/jac/7.6.643 Sullivan, 1993, Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumonia by using a mouse protection model, Antimicrob. Agents Chemother., 37, 234, 10.1128/AAC.37.2.234 Villa, 2005, Flumequine in the goat: pharmacokinetics after intravenous and intramuscular administration, Vet. Res. Commun., 29, 689, 10.1007/s11259-005-3867-7 Villa, 2005, Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration, Vet. J., 170, 101, 10.1016/j.tvjl.2004.05.012 Vree, 1992, Direct-gradient high-performance liquid chromatographic analysis and preliminary pharmacokinetics of flumequine and flumequine acyl glucuronide in humans: effect of probenecid, J. Chromatogr., 579, 131, 10.1016/0378-4347(92)80371-V Wagner, 1975 Wagner, 1976, Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data, J. Pharmacokinet. Biopharm., 4, 443, 10.1007/BF01062831 Yamaoka, 1978, Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations, J. Pharmacokinet. Biopharm., 6, 165, 10.1007/BF01117450 Yorke, 2000, Quantitation of nine quinolones in chicken tissues by high-performance liquid chromatography with fluorescence detection, J. Chromatogr. A, 882, 63, 10.1016/S0021-9673(00)00165-5 Ziv, 1986, Clinical pharmacokinetics of flumequine in calves, J. Vet. Pharmacol. Ther., 9, 171, 10.1111/j.1365-2885.1986.tb00027.x